This insight brief examines how the Functional Service Provider (FSP) model has evolved beyond large pharmaceutical companies to support mid-sized and emerging biopharma organizations. It outlines current market dynamics, including rising development costs, talent shortages, and increasing operational complexity, which are driving greater adoption of flexible outsourcing models. The brief explains how modern FSP solutions offer scalable expertise, cost control, and operational consistency across clinical functions. It addresses challenges smaller organizations face, such as limited internal infrastructure and budget constraints, and shows how tailored FSP strategies can fill capability gaps without sacrificing control. Guidance is provided on defining the right outsourcing strategy, design

Join for free to read